Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria
- PMID: 28352561
- PMCID: PMC5361133
- DOI: 10.1016/j.btre.2016.12.008
Synergistic effect of haloduracin and chloramphenicol against clinically important Gram-positive bacteria
Abstract
The emergence of drug-resistant pathogens has triggered the search for more efficient antimicrobial agents and formulations for treatment of infections. In recent years, combination therapy has become one of the effective clinical practices in treating infections. The present study deals with the effect of haloduracin, a lantibiotic bateriocin and chloramphenicol against clinically important bacteria. The combined use of haloduracin and chloramphenicol resulted in remarkable synergy against a spectrum of microorganisms including strains of Staphylococcus aureus, Enterococcus faecium, Enterococcus faecalis and different groups of Streptococcus. The synergy allowed using these antimicrobial agents at substantially reduced concentrations without compromising their efficiency. Use of lower doses of chloramphenicol can avoid the severity of its side effects. In addition to minimizing undesirable side effects of some drugs, this approach brings the possibility of using antibiotics that are no longer effective due to drug resistance. Furthermore, the observed synergy between haloduracin and chloramphenicol opens a new window of using bacteriocins and antibiotics in combination therapy of infections.
Keywords: Chloramphenicol; Combination therapy; Drug resistance; Haloduracin; Topical antibiotics.
Figures


Similar articles
-
Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.Microb Drug Resist. 2017 Jun;23(4):507-515. doi: 10.1089/mdr.2016.0030. Epub 2016 Aug 15. Microb Drug Resist. 2017. PMID: 27526275
-
Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.J Glob Antimicrob Resist. 2017 Sep;10:70-74. doi: 10.1016/j.jgar.2017.03.012. Epub 2017 Jun 30. J Glob Antimicrob Resist. 2017. PMID: 28673701
-
[Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].Jpn J Antibiot. 2003 Dec;56(6):546-73. Jpn J Antibiot. 2003. PMID: 15007872 Japanese.
-
Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century.Expert Rev Anti Infect Ther. 2014 Feb;12(2):249-64. doi: 10.1586/14787210.2014.878647. Epub 2014 Jan 6. Expert Rev Anti Infect Ther. 2014. PMID: 24392752 Review.
-
Treatment options for vancomycin-resistant enterococcal infections.Drugs. 2002;62(3):425-41. doi: 10.2165/00003495-200262030-00002. Drugs. 2002. PMID: 11827558 Review.
Cited by
-
An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.Antimicrob Agents Chemother. 2020 May 21;64(6):e02050-19. doi: 10.1128/AAC.02050-19. Print 2020 May 21. Antimicrob Agents Chemother. 2020. PMID: 32179527 Free PMC article.
-
Broadening and Enhancing Bacteriocins Activities by Association with Bioactive Substances.Int J Environ Res Public Health. 2020 Oct 26;17(21):7835. doi: 10.3390/ijerph17217835. Int J Environ Res Public Health. 2020. PMID: 33114656 Free PMC article. Review.
References
-
- Laxminarayan R., Malani A. Earthscan; 2007. Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance.http://www.cddep.org/publications/extending_cure_policy_responses_growin...
-
- WHO . WHO; 2010. Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response.
-
- WHO . WHO; 2011. Antimicrobial Resistance.http://www.who.int/mediacentre/factsheets/fs194/en/
-
- Gerberding J. National Academic Press; Washington, D.C: 2003. The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment; pp. 210–215. - PubMed
-
- Ejim L., Farha M.A., Falconer S.B., Wildenhain J., Coombes B.K., Tyers M., Brown E.D., Wright G.D. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 2011;7:348–350. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases